Meet us at

BIO-Europe Spring 2016

April 4 - 6, 2016

Stockholm, Sweden

Latest news

2013-10-16

First patient dosed in Synphora’s Phase II/III study of latanoprost as a treatment for Menière’s disease

October 16, 2013 - STOCKHOLM, Sweden. Synphora AB announced today that dosing has been initiated in a randomized, multicenter, double-blind Phase II/III study of latanoprost as a treatment for Menière’s disease. A total of 120 patients will be included in the trial. 

2012-03-11

Prosper Menière Society’s Gold Medal Award

March 11, 2012  - STOCKHOLM, Sweden. Synphora AB announced today that Professor Helge Rask-Andersen, Uppsala University Hospital, Uppsala, Sweden has been awarded the Prosper Menière Society’s Gold Medal Award for 2012.

2011-10-24

Synphora completes equity financing and William Gunnarsson joins the Board

October 24, 2011 - STOCKHOLM, Sweden. Synphora AB announced today that it has successfully completed an equity issue to fund the further development of its novel treatments for Menière’s disease and noise-induced tinnitus. There is currently no effective treatment for neither of these diseases.

William Gunnarsson representing BWG Holding, the lead investor in this financing round, will also join the Board of Directors of the Company.

Hemsida av Webbyrå KA Stockholm